Stay updated on Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial

Sign up to get notified when there's something new on the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The location label 'Padua, Italy 35128' was updated to 'Padova, Italy 35128' in the locations list.
    Difference
    0.0%
    Check dated 2026-04-09T07:53:02.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Added B-cell chronic lymphocytic leukemia as a disease term on the page. Included a resources section linking the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-04-02T00:11:01.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-25T20:13:13.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Site revision updated to v3.4.3; the previous revision v3.4.2 has been removed.
    Difference
    0.0%
    Check dated 2026-03-11T16:48:23.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Deleted the notice about a lapse in government funding, and the page now reflects the new revision. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T09:51:33.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    A government funding status notice was added and the page revision tag was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T05:48:40.000Z thumbnail image

Stay in the know with updates to Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page.